Gara Group Files Lawsuit Against Holista Colltech, Ltd., an Australia Limited Company, iGalen International, Inc. and Dr. Rajendran Manickavsagar
MIAMI, Oct. 18, 2021 /PRNewswire/ -- On October 13, 2021, Gara Group Inc., the industry's leading development firm that provides white-glove solutions to companies in the direct sales industry, filed a counterclaim in the Circuit Court in and for Broward County, Florida against Holista Colltech, Ltd. ("Holista"), iGalen International, Inc. ("iGalen"), and Dr. Rajendran Manickavsagar, also known as Dr. Rajen...
Innovent Announces ORIENT-31, a Phase 3 Study of Sintilimab in Patients with EGFR-Mutated Nonsquamous Non-Small Cell Lung Cancer with Prior EGFR-TKI Treatment, Has Met Primary Endpoint
SAN FRANCISCO and SUZHOU, China, Oct. 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today announced that the sintilimab ORIENT-31 study has met its prespecified primary endpoint of progression-free survival (PFS) at the first interim...
AFT Launches NZ-Made, 100% Natural, 90% Recyclable Hemptuary® Skincare Range
SYDNEY, Oct. 18, 2021 /PRNewswire/ -- Skincare mavens and beauty gurus have a new product to not only feel good in but feel good about – AFT Pharmaceuticals' new skincare range, Hemptuary®, is made in New Zealand from 100% natural ingredients and has packaging that is 90% recyclable. Hemptuary's Face & Body Oil is infused with hemp...
Concord Medical Files 2020 Annual Report on Form 20-F
BEIJING, Oct. 16, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers, premium cancer hospitals, and specialty cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it filed its annual report on Form 20-F for...
Webinar on Healthcare Innovations for Sustainable Future by Kalkine Media on October 21, 2021
SYDNEY, Oct. 16, 2021 /PRNewswire/ -- Ensuring healthy lives and promoting physical and mental well-being is essential to sustainable development. Currently, the world is facing a global health crisis unlike any other. Global health has increasingly gained international visibility and prominence. From big data to precision medicine, the recent advances in biomedical research have swept away the...
Novavax to Participate in World Vaccine Congress Europe
GAITHERSBURG, Md., Oct. 16, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a presentation during the World Vaccine Congress Europe 2021. A topic of discussion will be...
Neusoft Ranks Top in China Healthcare Security Informatization Market
SHENYANG, China, Oct. 15, 2021 /PRNewswire/ -- According to the Market Shares of Healthcare Security Information System of China 2020: Building a New Healthcare Security Information System recently released by International Data Corporation (IDC) for the first time, Neusoft Corporation ("Neusoft", SSE: 600718) ranks the top in the healthcare security information system market of China based on its comprehensive advantages such as...
CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform
HANGZHOU, China, Oct. 15, 2021 /PRNewswire/ -- On Oct. 11th, 2021, CellOrigin Inc. released data about its second generation of iPSC-CAR-Macrophage which has a genetically integrated secondary signal to confer controlled CAR-iMac polarization, in the 5th International Conference of IGC China, 2021, Beijing. Recently, CellOrigin Biotech, a company committed to iPSC-derived innate immune cell therapeutics, has announced a...
Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And Published In The Lancet Respiratory Medicine
TAIPEI, Oct. 15, 2021 /PRNewswire/ -- The Lancet Respiratory Medicine, one of the world's best-known peer-reviewed medical journals has published Medigen Vaccine Biologics (MVC) data from its MVC-COV1901 vaccine phase 2 clinical trial which demonstrates promising immunogenicity and safety profiles. The internationally trusted source of clinical, public and global health knowledge has made available the results from a large-scale,...
Antengene to Present Data of Its PD-L1/4-1BB Bispecific Antibody ATG-101 and ERK1/2 Inhibitor ATG-017 at SITC 2021
SHANGHAI and HONG KONG, Oct. 15, 2021 /PRNewswire/ -- The 36th Annual Meeting of the Society for Immunotherapy for Cancer (SITC 2021) will take place in Washington, D.C., United States, on November 10-14, 2021. The SITC's annual meeting is the world's largest gathering in the field of immuno-oncology. The event is dedicated to...
